Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...
The Food and Drug Administration has expanded the use of Pfizer’s pneumonia vaccine, allowing adults age 18 through 49 to receive the vaccine, according to Reuters. The vaccine, called Prevnar, is ...
Morning Overview on MSN
Universal nasal spray vaccine could block COVID, flu, and pneumonia
Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results